Latest News
August 12, 2022
Congratulations to Dr Christine Muttiah on receiving the inaugural 2022 BCT Clinical Fellowship award!
We are delighted to announce that Dr Christine Muttiah, TransBCR Clinical Fellow, is a recipient of the inaugural 2022 Breast Cancer Trials Clinical Fellowship Program award. As part of the Fellowship, Dr Muttiah will seek to explore methods to improve recruitment to clinical trials, including a centralised database to facilitate recruitment to the BRCA-P trial.
​
Learn more about the Breast Cancer Trials 2022 Clinical Fellowship Projects
May 18, 2021
BRCA-P trial participant tells their story
In this video produced by Breast Cancer Trials, Samantha, a Melbourne participant of the BRCA-P trial talks about her experiences of being on the study.
​
October 22, 2019
PALVEN clinical trial
opens it's doors at
Peter Mac and Royal Melbourne Hospitals
A new clinical trial assessing the use of a triple combination therapy in advanced metastatic breast cancer - PALVEN - has opened today, and is recruiting patients at the Peter MacCallum Cancer Centre and the Royal Melbourne Hospital.
October 01, 2019
The international
breast cancer prevention trial 'BRCA-P' officially opens!
Today is the official launch of the "BRCA-P" clinical trial being led in Australia by Breast Cancer Trials. This is the first global clinical trial that aims to prevent breast cancer in women with the BRCA1 gene mutation.
​
TransBCR will oversee the BRCA-P trial at the Peter Mac and Royal Melbourne Hospitals
July 31, 2019
Upcoming BRCA-P study making headlines
BRCA-P, an international breast cancer prevention study for women that have the BRCA1 mutation, will shortly be opening its doors in Australia. The study sponsored nationally by Breast Cancer Trials will see its lead site opened through the Centre for Translational Breast Cancer Research (TransBCR) in Melbourne in the coming months.
​
​
Media coverage ABC News
December 07, 2018
m-BEP study finds novel treatment combination brings new breast cancer hope
In a world first, breast cancer researchers at The Royal Melbourne Hospital, Peter MacCallum Cancer Centre and The Walter and Eliza Hall Institute of Medical Research, have successfully combined a drug used to treat chronic leukaemia with therapy used to treat breast cancer. The findings were published in the journal Cancer Discovery.
​
​
Media coverage Royal Melbourne Hospital
